NR3C2 and cardiac amyloidosis: For instance, the treatment of cardiac amyloidosis is mainly based on the management of symptoms related to HF, with loop diuretics (particularly torsemide and bumetanide), possibly coupled with mineralocorticoid receptor antagonists, being the cornerstone of therapy (41).